Browsing by Author JT Lin

Showing results 1 to 5 of 5

Issue Date	Title	Author(s)	Relation	scopus	WOS	Fulltext/Archive link
2018	Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B	YC Hsu; TCF Yip; HJ Ho; VWS Wang; YT Huang ; HB El-Serag; TY Lee; MS Wu; JT Lin; GLH Wong; CY Ying	JOURNAL OF HEPATOLOGY 69(2), 278-285
2021	Fibrosis in Patients with Chronic Hepatitis B and Minimally Raised ALT during Tenofovir Therapy – Authors’ reply	YC Hsu; YT Huang ; JT Lin	LANCET INFECTIOUS DISEASES 21(7), 911
2022	Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation	YC Hsu; V Suri; MH Nguyen; YT Huang ; CY Chen; IW Chen; CH Tseng; CY Wu; JT Lin; D Pan; A Gaggar; Ondrej Podlaha	Gastroenterology 162(4), 1160-1170.e1
2021	Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial	YC Hsu; CY Chen; IW Chang; CY Chang; CY Wu; TY Lee; MS Wu; MJ Bair; JJ Chen; CC Chen; CH Tseng; CM Tai; YT Huang ; WH Ku; LR Mo; JT Lin	LANCET INFECTIOUS DISEASES 21(6), 823-833
2018	Serum M2BPGi level and risk of hepatocellular carcinoma after oral anti‐viral therapy in patients with chronic hepatitis B	YC Hsu; T Jun; YT Huang ; ML Yeh; CL Lee; SH Cho; JT Lin; ML Yu; MH Nguyen; Y Tanaka	ALIMENTARY PHARMACOLOGY & THERAPEUTICS 48(10), 1128-1137

Showing results 1 to 5 of 5